|Bid||0.00 x 800|
|Ask||90.00 x 800|
|Day's range||81.48 - 84.08|
|52-week range||52.17 - 85.00|
|PE ratio (TTM)||90.04|
|Earnings date||22 Aug 2018 - 27 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||80.08|
Veeva Systems Inc (NYSE:VEEV) saw a decent share price growth in the teens level on the NYSE over the last few months. As a large-cap stock with high coverage byRead More...
Veeva Systems (VEEV) today announced that leading pharmaceutical companies and CROs are now using Veeva Vault EDC to improve data management in their clinical trials. In just over a year since the product’s availability, 12 early adopters have initiated studies with Vault EDC, including a top 20 global pharmaceutical company. “The ability to effectively manage clinical data is essential as trials become more complex,” said Alison Liddy, SVP clinical risk and data management at ICON, who is running a trial on behalf of a customer leveraging Veeva Vault EDC.
At the upcoming DIA 2018 Annual Meeting, Tufts Center for the Study of Drug Development (CSDD) will preview its study findings on the root causes for delays and inefficiencies impacting trial timelines. As a follow-up to the 2017 eClinical Landscape Study, sponsored by Veeva Systems (VEEV), Tufts CSDD spoke with more than 40 data management executives about the top challenges and opportunities in clinical data management. Findings indicate there is a significant opportunity to transform data management practices for greater agility and to accelerate adoption of risk-based approaches.
The media went full throttle in covering the exit of centuries-old GE from the Dow Jones industrial average, but the truly dynamic action for investors continued to center on fast-growing companies on the Nasdaq, including PayPal and Alphabet.
Stock futures were little changed. Alibaba, ServiceNow, Red Hat, Veeva Systems are all in buy zones and on the Rising Profit Estimates list.
Veeva Systems Inc. a leading industry cloud provider for life sciences, today announced that Tim Cabral, CFO, will present at the Bank of America Merrill Lynch 2018 Global Technology Conference on Wednesday, June 6, 2018, at 2:20 p.m.
Veeva Systems (VEEV) today announced Veeva Vault Training, a new cloud application to simplify role-based training across life sciences organizations and help quality teams remain audit-ready and compliant. Together with Veeva Vault QMS and Veeva Vault QualityDocs, Veeva will deliver a unified suite of quality applications on a single cloud platform that brings together training with quality processes and document control for seamless, end-to-end quality management.
Here are some things going on today in the world of tech: Shares of streaming pioneer Roku (ROKU) are up $1.61, or 4.5%,% at $37.60, after noted short-selling firm Citron Research announced that it is reversing its short call on the stock—first issued just after the company’s November IPO—after concluding the stock is undervalued relative to peers in the “over the top,” or OTT, video market. In a report posted online, with no byline, the firm notes Roku shares are "trading at the largest discount ever to OTT peers despite being the only OTT pure play that generates ad revenue." The authors point out Roku's multiple of enterprise value to sales relative to Netflix (NFLX) and ad broker Trade Desk (TTD) is so low that Roku "has gone from the most expensive to by far the cheapest" segment play.
The stock market was mixed to close out the week ahead of the three-day Memorial Day weekend. PayPal received an analyst upgrade.
Stock futures rose early Friday. Splunk, Veeva, Ross Stores and Deckers Outdoor closed in buy range, but were active overnight on earnings. Autodesk, near a buy point, also reported earnings.
Regarding the selloff this evening in Nutanix—the stock is now down only 4%, versus a 7% drop earlier—I spoke with CEO Dheeraj Pandey by phone a short while ago. Nutanix is very focused on free cash flow, he repeated. Pandey’s larger point was that the company is balancing growth and profit, by focusing on free cash flow.
Veeva Systems shares rose in late trading Thursday after the medical software maker beat first-quarter sales and earnings expectations.
PLEASANTON, Calif. (AP) _ Veeva Systems Inc. (VEEV) on Thursday reported fiscal first-quarter profit of $44.3 million. On a per-share basis, the Pleasanton, California-based company said it had net income of 29 cents. The results exceeded Wall Street expectations.
Veeva Systems Inc. , a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal first quarter ended April 30, 2018.
Stocks indexes were volatile after President Trump canceled his upcoming summit with North Korean President Kim Jong Un.
Splunk is in buy range ahead of its quarterly report Thursday and Veeva Systems is near an entry, while retail earnings continue with Best Buy, Ross Stores and Gap.
Veeva Systems' (VEEV) Q1 earnings to benefit from growing demand for cloud-based and vault applications, new product launches, industry focus approach along with international expansion.